KEGG: ecp:ECP_3087
E. coli and yeast expression systems generally provide the highest yields and shortest turnaround times for UPF0114 protein YqhA production. When post-translational modifications are critical for correct protein folding or activity retention, expression in insect cells with baculovirus or mammalian cells may be preferable, though these systems typically yield lower quantities of protein .
The expression system selection should be guided by your specific research objectives:
| Expression System | Advantages | Disadvantages | Optimal Application |
|---|---|---|---|
| E. coli | High yield, rapid production, cost-effective, technically feasible | Lacks post-translational modifications, potential inclusion body formation | Structural studies, high-throughput screens |
| Yeast | Post-translational capabilities (O-linked glycosylation, phosphorylation, acetylation), cost-effective | N-linked glycosylation patterns differ from higher eukaryotes | Applications requiring basic PTMs |
| Insect/Baculovirus | More complex PTMs, proper protein folding | Lower yield, longer production time | Functional studies requiring native-like folding |
| Mammalian cells | Full spectrum of PTMs, native-like folding | Lowest yield, highest cost, longest production time | Applications requiring authentic human PTMs |
The choice of replication origin significantly impacts recombinant protein expression levels. For UPF0114 protein YqhA expression in E. coli BL21, two commonly used origins with distinct copy numbers are p15A (approximately 10 copies/cell) and high-copy pMB1' (500-700 copies/cell) .
The replication origin influences protein yield through several mechanisms:
Experimental data indicates that the optimal replication origin depends on the specific promoter system and growth conditions. For instance, p15A origin combined with the trc promoter has demonstrated exceptional expression levels in E. coli when grown on glycerol as a carbon source .
Promoter selection is crucial for achieving desired expression levels of UPF0114 protein YqhA. Several promoter systems have been extensively evaluated for recombinant protein expression in E. coli, including P<sub>T7</sub>, P<sub>lac</sub>, P<sub>trc</sub>, and P<sub>araBAD</sub> .
| Promoter | Induction Method | Expression Level | Control Precision | Recommendation |
|---|---|---|---|---|
| P<sub>T7</sub> | IPTG | Very high | Moderate | High-yield applications, requires T7 RNA polymerase |
| P<sub>lac</sub> | IPTG | Low-moderate | Good | Applications requiring moderate expression |
| P<sub>trc</sub> | IPTG | High | Good | Balance of high expression and tight control |
| P<sub>araBAD</sub> | L-arabinose | Moderate | Excellent | Applications requiring precise expression control |
Research has demonstrated that the combination of promoter system and replication origin significantly affects expression outcomes. A combination of p15A origin with the trc promoter shows particularly promising results for high-level expression while maintaining cellular health .
Optimizing culture conditions for UPF0114 protein YqhA expression requires systematic evaluation of multiple parameters:
Carbon source selection: Glycerol often provides superior expression levels compared to glucose for E. coli expression systems, likely due to reduced catabolite repression. Experimental evidence shows significantly higher YFP reporter protein expression (used as a model for recombinant protein expression) in E. coli grown on glycerol compared to glucose under identical induction conditions .
Metabolic engineering approaches: Targeted genetic modifications can enhance production capacity. For instance, deleting the acetate kinase gene (ΔackA) has been shown to reduce acetate production and potentially improve recombinant protein yields in some expression systems .
Induction parameters: Optimize inducer concentration (typically 0.1 mM IPTG for lac-based promoters or 2 mM L-arabinose for araBAD promoter), induction timing (typically at mid-log phase), and temperature post-induction (often reduced to 25-30°C to improve protein folding) .
The following methodology is recommended for systematic optimization:
Begin with small-scale cultures (25-50 mL) testing combinations of:
Expression vectors (varying promoters and origins)
E. coli strains (wild-type vs. metabolically engineered)
Carbon sources (glucose vs. glycerol)
Induction conditions (concentration, OD at induction, temperature)
Quantify expression using fluorescence (if using reporter fusion), SDS-PAGE densitometry, or Western blot analysis
Scale up production using optimal conditions identified in preliminary experiments
Purification of UPF0114 protein YqhA requires a thoughtful approach that preserves structural integrity while achieving high purity. While the search results don't provide specific purification protocols for YqhA, general methodological principles for recombinant proteins with similar characteristics should be applied:
Affinity tag selection: For UPF0114 protein YqhA, common fusion tags include:
His<sub>6</sub> tag for IMAC purification (minimal impact on structure)
GST tag for glutathione affinity (enhances solubility)
MBP tag for maltose affinity (significantly improves solubility)
Cell lysis optimization: Gentle lysis methods should be employed to preserve native structure:
Enzymatic lysis with lysozyme (0.2-1 mg/mL) in combination with freeze-thaw cycles
Sonication with short pulses (10 seconds on/50 seconds off) to minimize heat denaturation
For membrane-associated proteins, use mild detergents (0.5-1% NP-40 or Triton X-100)
Multi-step purification strategy:
Initial capture step using affinity chromatography
Intermediate purification using ion exchange chromatography
Polishing step using size exclusion chromatography
Buffer optimization: Screen multiple buffer conditions for optimal stability:
pH range (typically 6.5-8.0)
Salt concentration (typically 100-500 mM NaCl)
Addition of stabilizing agents (5-10% glycerol, 1-5 mM reducing agents)
Studying interactions between E. coli O6:K15:H31 capsular polysaccharide and UPF0114 protein YqhA requires careful experimental design. The K15 capsular polysaccharide has a repeating structure consisting of 4)-α-Glc<i>p</i>NAc-(1 → 5)-α-KDO<i>p</i>-(2 → that is partially <i>O</i>-acetylated at the 3-hydroxyl of GlcNAc .
A comprehensive experimental approach would include:
Capsular polysaccharide isolation and characterization:
Protein-polysaccharide interaction assays:
Surface plasmon resonance (SPR) to determine binding kinetics
Isothermal titration calorimetry (ITC) for thermodynamic parameters
Pull-down assays with immobilized polysaccharide to confirm direct interactions
Structural analysis of complexes:
X-ray crystallography of YqhA-polysaccharide complexes
Cryo-electron microscopy for larger assemblies
NMR spectroscopy for dynamic interaction mapping
Functional studies:
Site-directed mutagenesis of potential binding residues in YqhA
Competition assays with synthesized polysaccharide fragments
In vivo studies comparing wild-type and YqhA-deficient strains
Mass spectrometry-based proteomics offers powerful approaches for identifying UPF0114 protein YqhA interactions in complex cellular environments. Several methodologies can be employed:
Affinity purification-mass spectrometry (AP-MS):
Express tagged YqhA in E. coli O6:K15:H31
Perform gentle cell lysis to preserve protein-protein interactions
Capture protein complexes via affinity purification
Identify interacting partners by LC-MS/MS
Distinguish true interactions from background using quantitative approaches (SILAC, TMT labeling)
Proximity-dependent biotinylation (BioID/TurboID):
Generate fusion of YqhA with a promiscuous biotin ligase
Express in native environment and activate with biotin
Capture biotinylated proteins (proximity partners)
Identify by LC-MS/MS
This method captures transient and weak interactions that may be lost in AP-MS
Cross-linking mass spectrometry (XL-MS):
Treat live cells with membrane-permeable crosslinkers
Isolate YqhA and crosslinked partners
Perform tryptic digestion and identify crosslinked peptides by MS
This provides structural information about interaction interfaces
Data analysis with specialized tools:
When reporting protein groups from MS data, researchers should consider implications of identification strategies:
"Majority Protein IDs" (most common in literature)
"Leading Proteins" (proteins with highest number of peptides)
Distinguishing UPF0114 protein YqhA from similar proteins in proteomics studies presents significant challenges due to sequence similarities and peptide sharing. To address this challenge:
Employ strategic peptide selection:
Identify unique peptides (not shared with other proteins) for YqhA identification
Target longer peptides (>10 amino acids) which are more likely to be unique
Consider post-translational modifications that may be specific to YqhA
Apply advanced mass spectrometry techniques:
Implement sophisticated data analysis:
Consider the impact of protein group handling:
Different accessions in the same protein group usually have similar sequences but may not share the same functional Gene Ontology (GO) annotations
GO-term enrichment is relatively robust when analyzing global proteomics datasets
Network generation is strongly impacted by which single gene is selected from a protein group
Advanced computational analysis of UPF0114 protein YqhA function requires specialized tools to integrate structural, genomic, and interaction data:
Protein-protein interaction network analysis:
Utilize the Cytoscape app Proteo Visualizer (https://apps.cytoscape.org/apps/ProteoVisualizer) to retrieve interaction networks from STRING database using protein groups as input
Calculate edge scores by summing all existing edges and dividing by the number of possible edges that could connect protein groups
Apply network visualization techniques that highlight protein groups with dashed edge lines when confidence scores fall below specified cutoffs
Gene Ontology (GO) enrichment analysis:
Calculate information content for each term t as ic(t) = -log(p(t)), where p(t) = freq(t)/freq(root)
Determine remaining uncertainty (ru) and missing information (mi) for protein pairs using established formulas
Recognize that collapsing protein groups requires aggregating numeric attributes like COMPARTMENTS and TISSUES confidence scores
Comparative genomics approaches:
Structure-function prediction:
Employ homology modeling if crystallographic data is unavailable
Use molecular dynamics simulations to predict functional motions
Apply machine learning approaches to predict protein-polysaccharide binding sites
Recombinant expression of UPF0114 protein YqhA in E. coli faces several challenges that require systematic troubleshooting approaches:
Inclusion body formation:
Problem: Overexpressed YqhA may aggregate into insoluble inclusion bodies
Solution strategies:
Metabolic burden and growth inhibition:
Problem: High-level expression can deplete cellular resources and inhibit growth
Solution strategies:
Inefficient translocation/transport:
Post-translational modification requirements:
Problem: E. coli lacks eukaryotic PTM machinery that may be required for full activity
Solution strategies:
Resolving contradictory data from different expression systems requires systematic investigation and data integration:
Characterize protein products from each system:
Perform mass spectrometry analysis to confirm protein identity and detect PTMs
Use circular dichroism spectroscopy to compare secondary structure profiles
Conduct thermal shift assays to evaluate structural stability
Compare enzymatic or binding activity using standardized assays
Identify system-specific variables:
Design validation experiments:
Express protein in multiple systems under standardized conditions
Perform parallel purification using identical protocols
Conduct side-by-side functional comparisons
Use orthogonal techniques to confirm contradictory findings
Statistical approach to data integration:
Apply meta-analysis techniques to evaluate data consistency across systems
Consider Bayesian approaches to update confidence in specific results
Implement principal component analysis to identify variables driving observed differences
Report all experimental conditions thoroughly to enable reproduction by other researchers
Resolving inconsistencies between computational predictions and experimental data for UPF0114 protein YqhA structure requires a methodical approach:
Evaluate prediction methodologies:
Assess the confidence scores of structure prediction algorithms
Consider template quality and coverage in homology modeling
Review force field parameters used in molecular dynamics simulations
Compare results from multiple prediction methods (AlphaFold, RoseTTAFold, I-TASSER)
Critical assessment of experimental data:
Evaluate resolution and quality metrics of crystallographic data
Consider dynamic regions that may adopt multiple conformations
Assess experimental conditions that might influence structural features
Review sample purity and potential for oligomerization or aggregation
Targeted validation experiments:
Design site-directed mutagenesis to test key structural predictions
Use hydrogen-deuterium exchange mass spectrometry to probe structural dynamics
Employ small-angle X-ray scattering (SAXS) to assess solution structure
Consider nuclear magnetic resonance (NMR) for regions with conformational flexibility
Integrate computational and experimental approaches:
Refine computational models using experimental constraints
Employ molecular dynamics simulations to explain experimental observations
Use enhanced sampling techniques to explore conformational landscapes
Develop ensemble models that may better represent the protein's native state
Advanced gene editing technologies offer transformative approaches for investigating UPF0114 protein YqhA function:
CRISPR-Cas9 genome editing applications:
Generate precise yqhA knockout strains without polar effects
Create point mutations to test specific functional hypotheses
Implement CRISPRi for conditional knockdown to study essential functions
Establish CRISPR activation systems to upregulate native expression
High-throughput mutagenesis approaches:
Employ saturation mutagenesis to comprehensively map functional residues
Implement deep mutational scanning coupled with functional selection
Create domain swap chimeras with related proteins to identify functional domains
Generate tagged variants for subcellular localization studies
Synthetic biology strategies:
Reconstitute potential YqhA-containing pathways in non-pathogenic chassis
Create synthetic genetic circuits to control YqhA expression dynamically
Implement optogenetic or chemogenetic control systems for temporal regulation
Design minimal expression systems to study YqhA function in isolation
Integration with systems biology:
Combine genomic, transcriptomic, and proteomic data to model YqhA function
Apply flux balance analysis to understand metabolic impacts of YqhA modulation
Implement genome-scale models to predict phenotypic consequences of YqhA alterations
Use multi-omics approaches to map the regulatory network surrounding YqhA
Emerging methodologies offer new avenues for investigating UPF0114 protein YqhA's role in pathogenesis:
Single-cell approaches:
Apply single-cell proteomics to study YqhA expression heterogeneity
Implement microfluidic systems to track individual cell responses
Use time-lapse microscopy with fluorescent reporters to monitor dynamic YqhA localization
Employ single-cell RNA-sequencing to correlate YqhA expression with global transcriptional changes
Cryo-electron tomography:
Visualize YqhA in its native cellular context at molecular resolution
Map interactions with cellular structures and potential binding partners
Study the structural impact of YqhA on capsular polysaccharide organization
Examine YqhA distribution during different growth phases and stress conditions
Host-pathogen interaction models:
Develop organoid infection models to study YqhA's role in pathogenesis
Implement tissue-on-chip technologies for controlled host-pathogen interactions
Use humanized mouse models to study YqhA function during infection
Apply dual RNA-seq to simultaneously track host and pathogen responses
Structural interactomics:
Apply hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map protein interaction surfaces
Implement integrative structural biology combining multiple data types
Use cross-linking mass spectrometry to capture transient interactions
Develop computational models of YqhA-containing protein complexes
Proteogenomic integration offers powerful approaches for elucidating UPF0114 protein YqhA function:
Custom database approaches:
Generate strain-specific protein databases that account for genomic variations
Include potential alternative start sites, splice variants, and processed forms
Incorporate predicted post-translational modifications
Apply specialized search algorithms to identify novel proteoforms
Multi-omics data integration:
Correlate YqhA protein abundance with transcriptional and translational efficiency
Map quantitative trait loci (QTLs) that influence YqhA expression or function
Identify co-regulated genes and proteins that may function in common pathways
Develop predictive models of YqhA's role in cellular networks
Evolutionary proteomics:
Compare YqhA sequence and structure across pathogenic and non-pathogenic strains
Identify conservation patterns that suggest functional constraints
Detect signatures of positive selection that may indicate host adaptation
Reconstruct the evolutionary history of YqhA and related UPF0114 family proteins
Functional annotation refinement:
Apply systematic phenotypic profiling of YqhA variants
Implement high-throughput assays to test predicted functions
Use comparative genomics to transfer functional annotations from characterized orthologs
Develop machine learning approaches to predict functional associations based on proteogenomic features